BioLight Life Sciences Ltd. (TLV:BOLT)

Israel · Delayed Price · Currency is ILS · Price in ILA

290.20

-10.00 (-3.33%)

Sep 8, 2026, 5:24 PM IDT

BioLight Life Sciences Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.11	3.98	9.72	5.28	13.39	33.47
Short-Term Investments	0.02	-	-	0.25	1.25	0.25
Trading Asset Securities	13.05	18.47	3.75	3.12	2.99	-
Cash & Short-Term Investments	16.19	22.44	13.47	8.64	17.63	33.71
Cash Growth	108.53%	66.65%	55.81%	-50.96%	-47.72%	-34.04%
Other Receivables	0.67	-	-	-	-	0
Receivables	0.67	-	-	-	-	0
Prepaid Expenses	-	0.44	0.44	0.07	0.09	0.04
Other Current Assets	-	1.52	0.44	0.34	0.31	0.25
Total Current Assets	16.86	24.4	14.35	9.06	18.02	34
Property, Plant & Equipment	4.65	4.32	4.16	4.27	3.34	3.26
Long-Term Investments	12.59	12.86	13.53	19.37	34.88	25.82
Other Intangible Assets	0.69	0.69	0.69	0.69	0.69	0.15
Other Long-Term Assets	0.27	0.15	1.4	0.07	0.09	0.95
Total Assets	35.06	42.41	34.12	33.45	57.01	64.17

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.41	0.08	0.13	0.24	0.3	0.15
Accrued Expenses	1.4	1.39	1.4	1.51	1.71	1.62
Current Portion of Leases	0.59	0.53	0.53	0.09	0.53	0.44
Current Unearned Revenue	-	-	-	0.48	-	-
Total Current Liabilities	2.41	2	2.07	2.32	2.54	2.21
Long-Term Leases	0.47	0.24	0.07	-	-	-
Long-Term Unearned Revenue	0.99	1.06	1.25	0.84	0.78	0.54
Total Liabilities	3.86	3.3	3.38	3.15	3.32	2.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	22.7	22.62	11.65	11.65	11.44	11.4
Additional Paid-In Capital	258.42	257.57	251.1	250.78	250.46	250.42
Retained Earnings	-267.81	-261.69	-249.97	-242.82	-216.8	-208.96
Comprehensive Income & Other	14.78	15.9	14.1	10.17	8.07	7.84
Total Common Equity	28.09	34.4	26.88	29.78	53.17	60.7
Minority Interest	3.1	4.71	3.86	0.53	0.52	0.72
Shareholders' Equity	31.19	39.11	30.74	30.3	53.69	61.42
Total Liabilities & Equity	35.06	42.41	34.12	33.45	57.01	64.17

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.06	0.77	0.6	0.09	0.53	0.44
Net Cash (Debt)	15.13	21.67	12.87	8.55	17.1	33.27
Net Cash Growth	103.84%	68.41%	50.47%	-49.98%	-48.61%	-33.70%
Net Cash Per Share	1.86	3.66	2.76	1.84	3.74	7.25
Filing Date Shares Outstanding	9.07	9.05	4.69	4.66	4.64	4.56
Total Common Shares Outstanding	9.07	9.05	4.66	4.66	4.58	4.56
Working Capital	14.45	22.4	12.28	6.74	15.49	31.79
Book Value Per Share	3.10	3.80	5.77	6.39	11.62	13.31
Tangible Book Value	27.4	33.72	26.19	29.09	52.48	60.55
Tangible Book Value Per Share	3.02	3.73	5.62	6.25	11.47	13.28
Machinery	-	0.56	0.56	0.64	0.64	0.54
Leasehold Improvements	-	-	-	0.07	0.07	0.07